Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.63% |
| 2 | Technology | 13.19% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Financials | 8.74% |
| 5 | Communication Services | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
Tootsie Roll Industries
TR
$3.05B
| $8.45M | 0.01% |
304,267
-111,181
| -27% | -$3.14M |
|
1552
Bridgewater Bancshares
BWB
$618M
| $8.38M | 0.01% |
607,747
+208,161
| +52% | +$2.64M |
|
1553
Crawford & Co Class B
CRD.B
$586M
| $8.37M | 0.01% |
824,317
-4,800
| -0.6% | -$47.1K |
|
1554
Arthur J. Gallagher & Co
AJG
$64.5B
| $8.36M | 0.01% |
87,800
-54,500
| -38% | -$4.99M |
|
1555
First Community Bankshares
FCBC
$932M
| $8.36M | 0.01% |
269,492
+5,800
| +2% | +$182K |
|
1556
First Northwest Bancorp
FNWB
$110M
| $8.36M | 0.01% |
460,905
+30,000
| +7% | +$526K |
|
1557
IES Holdings
IESC
$15.1B
| $8.35M | 0.01% |
325,532
+13,000
| +4% | +$281K |
|
1558
Rafael Holdings
RFL
$107M
| $8.32M | 0.01% |
472,879
-45,627
| -9% | -$831K |
|
1559
Vaalco Energy
EGY
$609M
| $8.32M | 0.01% |
3,747,190
+120,835
| +3% | +$240K |
|
|
WBT
1560
DELISTED
Welbilt, Inc.
WBT
| $8.31M | 0.01% |
532,400
+144,225
| +37% | +$2.47M |
|
1561
Blackstone Mortgage Trust
BXMT
$2.43B
| $8.3M | 0.01% |
223,080
-314,600
| -59% | -$11.4M |
|
|
SPTN
1562
DELISTED
SpartanNash
SPTN
| $8.27M | 0.01% |
581,012
+33,757
| +6% | +$446K |
|
|
PRGX
1563
DELISTED
PRGX Global, Inc.
PRGX
| $8.25M | 0.01% |
1,676,610
-16,800
| -1% | -$81.4K |
|
1564
Clearfield
CLFD
$390M
| $8.25M | 0.01% |
591,599
+27,700
| +5% | +$358K |
|
1565
Liberty Broadband Class A
LBRDA
$5.24B
| $8.23M | 0.01% |
66,100
-16,000
| -19% | -$1.85M |
|
1566
SPDR Gold Trust
GLD
$143B
| $8.22M | 0.01% |
+57,500
| New | +$8.04M |
|
1567
Ardmore Shipping
ASC
$721M
| $8.21M | 0.01% |
907,598
+232,100
| +34% | +$1.93M |
|
|
PBIP
1568
DELISTED
Prudential Bancorp, Inc.
PBIP
| $8.19M | 0.01% |
441,824
+1,524
| +0.3% | +$26.9K |
|
|
PLYM
1569
DELISTED
Plymouth Industrial REIT
PLYM
| $8.18M | 0.01% |
444,624
+47,919
| +12% | +$883K |
|
1570
Boise Cascade
BCC
$2.91B
| $8.17M | 0.01% |
223,600
+68,400
| +44% | +$2.48M |
|
|
AGRX
1571
DELISTED
Agile Therapeutics
AGRX
| $8.16M | 0.01% |
1,633
+419
| +35% | +$1.46M |
|
|
ASRT
1572
DELISTED
Assertio
ASRT
| $8.16M | 0.01% |
108,825
+13,387
| +14% | +$785K |
|
|
GFN
1573
DELISTED
General Finance Corporation
GFN
| $8.15M | 0.01% |
736,540
-10,078
| -1% | -$99.3K |
|
|
ZEPP
1574
Zepp Health
ZEPP
$81.4M
| $8.13M | 0.01% |
169,044
+50,419
| +43% | +$2.11M |
|
1575
Radian Group
RDN
$4.95B
| $8.12M | 0.01% |
322,900
-381,600
| -54% | -$9.49M |
|
Similar funds
Jim Simons's Q4 2019 Portfolio in Review
As of Q4 2019, Jim Simons held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jim Simons's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Jim Simons added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Jim Simons's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Jim Simons fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Jim Simons's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Jim Simons opened 518 new positions and closed 443 in Q4 2019.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.